A PYMNTS Company

EU: $13.4B orthopedic merger to meet its fate next month

By  |  September 1, 2014

The European Commission has announced that it will decide by October 3 whether to accept or deny plans of a $13.4 billion orthopedic merger.

According to reports, US-based orthopedic product maker Zimmer will receive a decision regarding its planned acquisition of rival Biomet next month. Zimmer first applied for EU approval of its plans last June, but the Commission had requested more information regarding the transaction, causing a delay to the ruling.

Reports say if cleared, the merger would make Zimmer the second-largest seller of orthopedic products behind Johnson & Johnson.

Full content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.